The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update
Open accessAbstract
A growing number of patients undergoing percutaneous coronary intervention (PCI) with stent implantation also have atrial fibrillation. This poses challenges for their optimal antithrombotic management because patients with atrial fibrillation undergoing PCI require oral anticoagulation for the prevention of cardiac thromboembolism and dual antiplatelet therapy for the prevention of coronary thrombotic complications. The combination of oral anticoagulation and dual antiplatelet therapy substantially increases the risk of bleeding. Over the last decade, a series of North American Consensus Statements on the Management of Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention have been reported. Since the last update in 2018, several pivotal clinical trials in the field have been published. This document provides a focused updated of the 2018 recommendations. The group recommends that in patients with atrial fibrillation undergoing PCI, a non–vitamin K antagonist oral anticoagulant is the oral anticoagulation of choice. Dual antiplatelet therapy with aspirin and a P2Y 12 inhibitor should be given to all patients during the peri-PCI period (during inpatient stay, until time of discharge, up to 1 week after PCI, at the discretion of the treating physician), after which the default strategy is to stop aspirin and continue treatment with a P2Y 12 inhibitor, preferably clopidogrel, in combination with a non–vitamin K antagonist oral anticoagulant (ie, double therapy). In patients at increased thrombotic risk who have an acceptable risk of bleeding, it is reasonable to continue aspirin (ie, triple therapy) for up to 1 month. Double therapy should be given for 6 to 12 months with the actual duration depending on the ischemic and bleeding risk profile of the patient, after which patients should discontinue antiplatelet therapy and receive oral anticoagulation alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Self-citationPrasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
Self-citationJanuary, C. T., Wann, L. S., Calkins, H., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000665 · Cited by 2,744
Steffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123
Bivalirudin during Primary PCI in Acute Myocardial Infarction
Stone, G. W., Witzenbichler, B., Guagliumi, G., Peruga, J. Z., Brodie, B. R., Dudek, D., Kornowski, R., Hartmann, F., Gersh, B. J., Pocock, S. J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708191 · Cited by 1,867
Self-citationDewilde, W. J., Oirbans, T., Verheugt, F. W., Kelder, J. C., De Smet, B. J., Herrman, J.-P., Adriaenssens, T., Vrolix, M., Heestermans, A. A., Vis, M. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62177-1 · Cited by 1,719
Prevention of bleeding in patients with atrial fibrillation undergoing PCI
Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F. W., Wildgoose, P., Birmingham, M., Ianus, J., Burton, P., van Eickels, M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1611594 · Cited by 1,590
Self-citationDual antithrombotic therapy with dabigatran after PCI in atrial fibrillation
Cannon, C. P., Bhatt, D. L., Oldgren, J., Lip, G. Y. H., Ellis, S. G., Kimura, T., Maeng, M., Merkely, B., Zeymer, U., Gropper, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708454 · Cited by 1,383
Self-citationAntithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation
Lopes, R. D., Heizer, G., Aronson, R., Vora, A. N., Massaro, T., Mehran, R., Goodman, S. G., Windecker, S., Darius, H., Li, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1817083 · Cited by 1,228
Self-citationCosta, F., van Klaveren, D., James, S., Heg, D., Räber, L., Feres, F., Pilgrim, T., Hong, M.-K., Kim, H.-S., Colombo, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30397-5 · Cited by 1,184
Self-citationEffect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
Bhatt, D. L., Stone, G. W., Mahaffey, K. W., Gibson, C. M., Steg, P. G., Hamm, C. W., Price, M. J., Leonardi, S., Gallup, D., Bramucci, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300815 · Cited by 840
Self-citationUrban, P., Mehran, R., Colleran, R., Angiolillo, D. J., Byrne, R. A., Capodanno, D., Cuisset, T., Cutlip, D., Eerdmans, P., Eikelboom, J., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040167 · Cited by 823
Self-citationPolymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk
Urban, P., Meredith, I. T., Abizaid, A., Pocock, S. J., Carrié, D., Naber, C., Lipiecki, J., Richardt, G., Iñiguez, A., Brunel, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503943 · Cited by 818
Mega, J., Braunwald, E., Mohanavelu, S., Burton, P., Poulter, R., Misselwitz, F., Hricak, V, Barnathan, E., Bordes, P., Witkowski, A., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60738-8 · Cited by 688
Self-citationVranckx, P., Valgimigli, M., Eckardt, L., Tijssen, J., Lewalter, T., Gargiulo, G., Batushkin, V., Campo, G., Lysak, Z., Vakaliuk, I., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31872-0 · Cited by 685
Task Force Members, Lip, G. Y. H., Windecker, S., Huber, K., Kirchhof, P., Marin, F., Ten Berg, J. M., Haeusler, K. G., Boriani, G., Capodanno, D., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu298 · Cited by 566
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
Yasuda, S., Kaikita, K., Akao, M., Ako, J., Matoba, T., Nakamura, M., Miyauchi, K., Hagiwara, N., Kimura, K., Hirayama, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1904143 · Cited by 565
Sibbing, D., Aradi, D., Alexopoulos, D., ten Berg, J., Bhatt, D. L., Bonello, L., Collet, J.-P., Cuisset, T., Franchi, F., Gross, L., et al. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.03.034 · Cited by 537
Self-citationGénéreux, P., Giustino, G., Witzenbichler, B., Weisz, G., Stuckey, T. D., Rinaldi, M. J., Neumann, F.-J., Metzger, D. C., Henry, T. D., Cox, D. A., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1323 · Cited by 454
Self-citationEfficacy and Safety of Dual Antiplatelet Therapy After Complex PCI
Giustino, G., Chieffo, A., Palmerini, T., Valgimigli, M., Feres, F., Abizaid, A., Costa, R. A., Hong, M.-K., Kim, B.-K., Jang, Y., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.07.760 · Cited by 454
Self-citationCORONARY REVASCULARIZATION WRITING GROUP, Patel, M. R., Dehmer, G. J., Hirshfeld, J. W., Smith, P. K., & Spertus, J. A. (2009) · Circulation · doi:10.1161/circulationaha.108.191768 · Cited by 448
Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes
Valgimigli, M., Frigoli, E., Leonardi, S., Rothenbühler, M., Gagnor, A., Calabrò, P., Garducci, S., Rubartelli, P., Briguori, C., Andò, G., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507854 · Cited by 397
International Expert Consensus on Switching Platelet P2Y 12 Receptor–Inhibiting Therapies
Angiolillo, D. J., Rollini, F., Storey, R. F., Bhatt, D. L., James, S., Schneider, D. J., Sibbing, D., So, D. Y. F., Trenk, D., Alexopoulos, D., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.031164 · Cited by 397
Self-citationACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy
Capodanno, D., Alfonso, F., Levine, G. N., Valgimigli, M., & Angiolillo, D. J. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.057 · Cited by 366
Self-citationTicagrelor in patients with stable coronary disease and diabetes
Steg, P. G., Bhatt, D. L., Simon, T., Fox, K., Mehta, S. R., Harrington, R. A., Held, C., Andersson, M., Himmelmann, A., Ridderstråle, W., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908077 · Cited by 365
Self-citationNovel antiplatelet agents in acute coronary syndrome
Franchi, F., & Angiolillo, D. J. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.156 · Cited by 353
Self-citationDual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting
Costa, F., Van Klaveren, D., Feres, F., James, S., Räber, L., Pilgrim, T., Hong, M.-K., Kim, H.-S., Colombo, A., Steg, P. G., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.048 · Cited by 325
Self-citationGargiulo, G., Goette, A., Tijssen, J., Eckardt, L., Lewalter, T., Vranckx, P., & Valgimigli, M. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz732 · Cited by 318
Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk
Windecker, S., Latib, A., Kedhi, E., Kirtane, A. J., Kandzari, D. E., Mehran, R., Price, M. J., Abizaid, A., Simon, D. I., Worthley, S. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910021 · Cited by 291
Self-citationLamberts, M., Gislason, G. H., Lip, G. Y. H., Lassen, J. F., Olesen, J. B., Mikkelsen, A. P., Sørensen, R., Køber, L., Torp-Pedersen, C., & Hansen, M. L. (2014) · Circulation · doi:10.1161/circulationaha.113.004834 · Cited by 284
Lopes, R. D., Hong, H., Harskamp, R. E., Bhatt, D. L., Mehran, R., Cannon, C. P., Granger, C. B., Verheugt, F. W. A., Li, J., ten Berg, J. M., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1880 · Cited by 240
Self-citationAngiolillo, D. J., Goodman, S. G., Bhatt, D. L., Eikelboom, J. W., Price, M. J., Moliterno, D. J., Cannon, C. P., Tanguay, J.-F., Granger, C. B., Mauri, L., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034722 · Cited by 238
Self-citationSarafoff, N., Martischnig, A., Wealer, J., Mayer, K., Mehilli, J., Sibbing, D., & Kastrati, A. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.036 · Cited by 236
Patients with atrial fibrillation and coronary artery disease – Double trouble
Michniewicz, E., Mlodawska, E., Lopatowska, P., Tomaszuk-Kazberuk, A., & Malyszko, J. (2018) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.06.005 · Cited by 236
Ray, W. A., Chung, C. P., Murray, K. T., Smalley, W. E., Daugherty, J. R., Dupont, W. D., & Stein, C. M. (2018) · JAMA · doi:10.1001/jama.2018.17242 · Cited by 222
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
Capodanno, D., Mehran, R., Valgimigli, M., Baber, U., Windecker, S., Vranckx, P., Dangas, G., Rollini, F., Kimura, T., Collet, J.-P., et al. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0049-1 · Cited by 214
Self-citationUeki, Y., Bär, S., Losdat, S., Otsuka, T., Zanchin, C., Zanchin, T., Gragnano, F., Gargiulo, G., Siontis, G. C. M., Praz, F., et al. (2020) · EuroIntervention · doi:10.4244/eij-d-20-00052 · Cited by 212
Matsumura-Nakano, Y., Shizuta, S., Komasa, A., Morimoto, T., Masuda, H., Shiomi, H., Goto, K., Nakai, K., Ogawa, H., Kobori, A., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036768 · Cited by 207
Steinberg, B. A., Shrader, P., Pieper, K., Thomas, L., Allen, L. A., Ansell, J., Chan, P. S., Ezekowitz, M. D., Fonarow, G. C., Freeman, J. V., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007633 · Cited by 205
Eikelboom, J., Berger, P., Holmes, D., Bhatt, D., Becker, R., Angiolill, D., Faxon, D., & Moliterno, D. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-04-0262 · Cited by 204
Self-citationTicagrelor With or Without Aspirin After Complex PCI
Dangas, G., Baber, U., Sharma, S. K., Giustino, G., Mehta, S. R., Cohen, D. J., Angiolillo, D. J., Sartori, S., Chandiramani, R., Briguori, C., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.011 · Cited by 179
Self-citationGibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F., Wildgoose, P., van Eickels, M., Lip, G. Y. H., Cohen, M., Husted, S., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2014.12.006 · Cited by 174
Self-citationManagement of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI
Capodanno, D., Huber, K., Mehran, R., Lip, G. Y. H., Faxon, D. P., Granger, C. B., Vranckx, P., Lopes, R. D., Montalescot, G., Cannon, C. P., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.05.016 · Cited by 169
Self-citationRossini, R., Musumeci, G., Lettieri, C., Molfese, M., Mihalcsik, L., Mantovani, P., Sirbu, V., Bass, T. A., Della Rovere, F., Gavazzi, A., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.08.021 · Cited by 167
Self-citationGolwala, H. B., Cannon, C. P., Steg, P. G., Doros, G., Qamar, A., Ellis, S. G., Oldgren, J., ten Berg, J. M., Kimura, T., Hohnloser, S. H., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy162 · Cited by 166
Self-citationAlexander, J. H., WOJDYLA, D. M., Vora, A. N., Thomas, L. E., Granger, C. B., Goodman, S. G., ARONSON, R. S., Windecker, S., Mehran, R., & Lópes, R. D. (2020) · Circulation · doi:10.1161/circulationaha.120.046534 · Cited by 144
Self-citationVerheugt, F. W. A., & Granger, C. B. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60245-8 · Cited by 137
Self-citationLópes, R. D., Hong, H., Harskamp, R. E., Bhatt, D. L., Mehran, R., Cannon, C. P., Granger, C. B., Verheugt, F. W. A., Li, J., ten Berg, J. M., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2019.6175 · Cited by 134
Self-citationLópes, R. D., Leonardi, S., WOJDYLA, D. M., Vora, A. N., Thomas, L. E., Storey, R. F., Vinereanu, D., Granger, C. B., Goodman, S. G., ARONSON, R. S., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.044584 · Cited by 125
Self-citationFaxon, D. P., Eikelboom, J. W., Berger, P. B., Holmes, D. R., Bhatt, D. L., Moliterno, D. J., Becker, R. C., & Angiolillo, D. J. (2011) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.111.965186 · Cited by 108
Self-citationRadial Access Reduces Mortality in Patients With Acute Coronary Syndromes
Andò, G., & Capodanno, D. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2015.12.008 · Cited by 100
Angiolillo, D. J., Goodman, S. G., Bhatt, D. L., Eikelboom, J. W., Price, M. J., Moliterno, D. J., Cannon, C. P., Tanguay, J., Granger, C. B., Mauri, L., et al. (2016) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.116.004395 · Cited by 94
Self-citationOrme, R. C., Parker, W. A., Thomas, M. R., Judge, H. M., Baster, K., Sumaya, W., Morgan, K. P., McMellon, H., Richardson, J. D., Grech, E. D., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034790 · Cited by 94
Oldgren, J., Steg, P. G., Hohnloser, S. H., Lip, G. Y. H., Kimura, T., Nordaby, M., Brueckmann, M., Kleine, E., ten Berg, J. M., Bhatt, D. L., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz059 · Cited by 92
Self-citationYu, H. T., Yang, P., Jang, E., Kim, T., Uhm, J., Kim, J., Pak, H., Lee, M., Lip, G. Y. H., & Joung, B. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014177 · Cited by 90
Capodanno, D., Maio, M. D., Greco, A., Bhatt, D. L., Gibson, C. M., Goette, A., Lópes, R. D., Mehran, R., Vranckx, P., & Angiolillo, D. J. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017212 · Cited by 86
Self-citationEvolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy
Moon, J. Y., Franchi, F., Rollini, F., & Angiolillo, D. J. (2017) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2017.12.004 · Cited by 81
Self-citationWindecker, S., Lópes, R. D., Massaro, T., Jones-Burton, C., Granger, C. B., ARONSON, R. S., Heizer, G., Goodman, S. G., Darius, H., Jones, W. S., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.043308 · Cited by 80
Self-citationCapodanno, D., & Angiolillo, D. J. (2014) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.113.001150 · Cited by 79
Self-citationCapodanno, D., Milluzzo, R. P., & Angiolillo, D. J. (2019) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944719893274 · Cited by 77
Self-citationGalli, M., Andreotti, F., Porto, I., & Crea, F. (2019) · EP Europace · doi:10.1093/europace/euz345 · Cited by 68
Vaduganathan, M., Harrington, R. A., Stone, G. W., Deliargyris, E., Steg, P. G., Gibson, C. M., Hamm, C. W., Price, M. J., Menozzi, A., Prats, J., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.055 · Cited by 58
Self-citationCardiovascular Therapies Targeting Left Atrial Appendage
Turagam, M. K., Velagapudi, P., Kar, S., Holmes, D. R., Reddy, V. Y., Refaat, M. M., Biase, L. D., Al‐Ahmed, A., Chung, M. K., Lewalter, T., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.048 · Cited by 56
Self-citationTailoring duration of DAPT with risk scores
Capodanno, D., & Angiolillo, D. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30591-3 · Cited by 54
Self-citationOlsen, A. S., McGettigan, P., Gerds, T. A., Fosbøl, E. L., Olesen, J. B., Sindet‐Pedersen, C., Stærk, L., Hansen, M. L., Pallisgaard, J. L., Køber, L., et al. (2019) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz069 · Cited by 42
Buccheri, S., Capodanno, D., James, S. K., & Angiolillo, D. J. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1680637 · Cited by 41
Self-citationCosta, F., Valgimigli, M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., ten Berg, J. M., Miede, C., Nordaby, M., Lip, G. Y. H., Oldgren, J., et al. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa135 · Cited by 41
Self-citationKernéis, M., Gibson, C. M., Chi, G., Mehran, R., Alkhalfan, F., Talib, U., Pahlavani, S., Mir, M., Bode, C., Halperin, J. L., et al. (2018) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.11.009 · Cited by 34
Self-citationVranckx, P., Valgimigli, M., Eckardt, L., Lewalter, T., Unikas, R., Marín, F. R., Schiele, F., Laeis, P., Reimitz, P., Smolnik, R., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa617 · Cited by 32
Berry, N. C., Mauri, L., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., Nordaby, M., Miede, C., Kimura, T., Lip, G. Y. H., Oldgren, J., et al. (2020) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.119.008349 · Cited by 29
Self-citationFranchi, F., Rollini, F., Been, L. F., Briceno, M., Maaliki, N., Wali, M., Rivas, A., Pineda, A. M., Suryadevara, S., Soffer, D. E., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.048770 · Cited by 15
Self-citationDual antithrombotic therapy for atrial fibrillation and PCI
Capodanno, D., & Angiolillo, D. J. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31954-3 · Cited by 12
Self-citationAtrial fibrillation, with ACS and PCI: walking a tightrope
Mehran, R., Kalkman, D. N., & Angiolillo, D. J. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz192 · Cited by 6
Self-citationBuccheri, S., Angiolillo, D. J., & Capodanno, D. (2019) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944719891688 · Cited by 6
Self-citation
Cited by
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598
Diagnosis and Treatment of Acute Coronary Syndromes: A Review
Bhatt, D. L., Lopes, R. D., & Harrington, R. A. (2022) · JAMA · doi:10.1001/jama.2022.0358 · Cited by 787
Self-citationGornik, H. L., Aronow, H. D., Goodney, P. P., Arya, S., Brewster, L. P., Byrd, L., Chandra, V., Drachman, D. E., Eaves, J. M., Ehrman, J. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001251 · Cited by 771
Urban, P., Mehran, R., Colleran, R., Angiolillo, D. J., Byrne, R. A., Capodanno, D., Cuisset, T., Cutlip, D., Eerdmans, P., Eikelboom, J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz372 · Cited by 621
Self-citationDual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
Valgimigli, M., Frigoli, E., Heg, D., Tijssen, J., Jüni, P., Vranckx, P., Ozaki, Y., Morice, M.-C., Chevalier, B., Onuma, Y., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2108749 · Cited by 593
Metadata
- Authors
- Angiolillo, D. J., Bhatt, D. L., Cannon, C. P., Eikelboom, J. W., Gibson, C. M., Goodman, S. G., Granger, C. B., Holmes, D. R., Lopes, R. D., Mehran, R., Moliterno, D. J., Price, M. J., Saw, J., Tanguay, J.-F., & Faxon, D. P.
- Venue
- Circulation
- Published
- 2021-02-09
- Volume
- 143
- Issue
- 6
- Pages
- 583-596
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2887586296
- Cited by
- 302
- References
- 77
- FWCI
- 27.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.